Comparar métodos

	Escala de Gravedad del Trastorno de Pánico	Inventario de Ansiedad de Beck	Trastorno de Ansiedad Generalizada-7
Campo	Psicología clínica	Psicología clínica	Psicología clínica
Familia	Process / pipeline	Process / pipeline	Process / pipeline
Año de origen	1997	1993	2006
Autor original	Katherine M. Shear, Timothy A. Brown, David H. Barlow, and collaborators	Aaron T. Beck, Robert A. Steer	Robert L. Spitzer, Kurt Kroenke, Janet B. Williams, Bernd Löwe
Tipo	Clinician-rated panic disorder scale	Self-report symptom inventory	Self-report screening questionnaire
Fuente seminal	Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., ... & Papp, L. A. (1997). Multicenter collaborative panic disorder severity scale. Depression and Anxiety, 5(4), 189-196.	Beck, A. T., & Steer, R. A. (1993). BAI: Beck Anxiety Inventory. San Antonio, TX: The Psychological Corporation. ISBN: 0158710050	Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092-1097.
Alias	PDSS	BAI	GAD-7
Relacionados	2	3	3
Resumen	The Panic Disorder Severity Scale (PDSS) is a brief 7-item clinician-administered scale designed to measure the severity of panic disorder symptoms, including panic attack frequency, distress, anxiety anticipation, agoraphobic avoidance, and interoceptive fear. Developed by Shear, Brown, Barlow, and collaborators in 1997, the PDSS has become the standard assessment tool for panic disorder severity in clinical trials, research, and routine practice.	The Beck Anxiety Inventory (BAI) is a 21-item self-report scale designed to measure the severity of somatic and cognitive symptoms of anxiety in adolescents and adults. Developed by Aaron T. Beck and Robert A. Steer in 1993, the BAI is widely used in clinical assessment, treatment monitoring, and research to quantify anxiety symptoms across a broad spectrum of anxiety disorders.	The GAD-7 is a brief 7-item self-report questionnaire designed to screen for and measure the severity of generalized anxiety disorder in adolescents and adults. Developed by Spitzer, Kroenke, Williams, and Löwe in 2006, it has become one of the most widely used anxiety screening tools in primary care, mental health research, and clinical practice due to its brevity, excellent psychometric properties, and ease of administration.